Related Experiment Videos
Status of current therapies for hypertension
1Department of Geriatrics, University of Uppsala, Sweden.
Insights
Antihypertensive therapy has advanced significantly over four decades, improving blood pressure management. Current research focuses on novel drug classes and optimal pressure targets for maximum patient benefit.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Antihypertensive therapy has been clinically utilized for approximately 40 years, witnessing substantial progress.
- The benefits of reducing elevated arterial pressure are well-established through numerous intervention trials.
Purpose of the Study:
- To review key advancements in hypertension treatment over past decades.
- To evaluate the current status of antihypertensive therapies.
- To highlight ongoing research areas, including novel therapies and blood pressure targets.
Main Methods:
- Review of historical intervention trials, from malignant to non-malignant hypertension.
- Examination of pharmacological principles in hypertension management.
- Analysis of ongoing large-scale intervention trials (CAPPP, NORDIL, HOT, STOP Hypertension-2).
Main Results:
- Significant progress in antihypertensive therapy over four decades.
- Documented value of lowering elevated arterial pressure.
- Introduction of numerous new pharmacological agents.
Conclusions:
- The review summarizes critical steps in hypertension treatment and evaluates current therapeutic status.
- Emphasis on novel therapies like calcium antagonists and ACE inhibitors.
- Discussion on the optimal blood pressure reduction for maximum therapeutic benefit.
Abstract:
Specific antihypertensive therapy has been in common clinical use for about four decades. During this relatively short period of time remarkable progress has been made in many regards. The value of lowering elevated arterial pressure has been documented in a number of intervention trials. Initially, such studies comprised patients with malignant hypertension only, but later large-scale studies have comprised patients with non-malignant forms of hypertension. At the same time numerous new pharmacological principles have been taken into clinical use in the treatment of hypertension. It is the purpose of this brief review to sum up some of the important steps that have been taken in this area during previous decades and to try to evaluate the status of current therapies for hypertension. Special emphasis will be given to some of the remaining issues and questions that are currently under investigation, such as the place of novel therapies, e.g. calcium antagonists and ACE-inhibitors, and the issue of the level to which blood pressure should be lowered in order to extract the maximum benefit of antihypertensive treatment. Some of the ongoing large-scale intervention trials in hypertension, e.g. the CAPPP Study, the NORDIL Study, the HOT Study and the STOP Hypertension-2 study, will be reviewed.